Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11438603rdf:typepubmed:Citationlld:pubmed
pubmed-article:11438603lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:11438603lifeskim:mentionsumls-concept:C0025148lld:lifeskim
pubmed-article:11438603lifeskim:mentionsumls-concept:C0001629lld:lifeskim
pubmed-article:11438603lifeskim:mentionsumls-concept:C0006121lld:lifeskim
pubmed-article:11438603lifeskim:mentionsumls-concept:C1550278lld:lifeskim
pubmed-article:11438603lifeskim:mentionsumls-concept:C0027796lld:lifeskim
pubmed-article:11438603lifeskim:mentionsumls-concept:C0066908lld:lifeskim
pubmed-article:11438603lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:11438603lifeskim:mentionsumls-concept:C0547070lld:lifeskim
pubmed-article:11438603lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:11438603pubmed:issue14lld:pubmed
pubmed-article:11438603pubmed:dateCreated2001-7-4lld:pubmed
pubmed-article:11438603pubmed:abstractTextNeurons in the rostroventromedial medulla (RVM) project to spinal loci where the neurons inhibit or facilitate pain transmission. Abnormal activity of facilitatory processes may thus represent a mechanism of chronic pain. This possibility and the phenotype of RVM cells that might underlie experimental neuropathic pain were investigated. Cells expressing mu-opioid receptors were targeted with a single microinjection of saporin conjugated to the mu-opioid agonist dermorphin; unconjugated saporin and dermorphin were used as controls. RVM dermorphin-saporin, but not dermorphin or saporin, significantly decreased cells expressing mu-opioid receptor transcript. RVM dermorphin, saporin, or dermorphin-saporin did not change baseline hindpaw sensitivity to non-noxious or noxious stimuli. Spinal nerve ligation (SNL) injury in rats pretreated with RVM dermorphin-saporin failed to elicit the expected increase in sensitivity to non-noxious mechanical or noxious thermal stimuli applied to the paw. RVM dermorphin or saporin did not alter SNL-induced experimental pain, and no pretreatment affected the responses of sham-operated groups. This protective effect of dermorphin-saporin against SNL-induced pain was blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist, indicating specific interaction of dermorphin-saporin with the mu-opioid receptor. RVM microinjection of dermorphin-saporin, but not of dermorphin or saporin, in animals previously undergoing SNL showed a time-related reversal of the SNL-induced experimental pain to preinjury baseline levels. Thus, loss of RVM mu receptor-expressing cells both prevents and reverses experimental neuropathic pain. The data support the hypothesis that inappropriate tonic-descending facilitation may underlie some chronic pain states and offer new possibilities for the design of therapeutic strategies.lld:pubmed
pubmed-article:11438603pubmed:languageenglld:pubmed
pubmed-article:11438603pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:citationSubsetIMlld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11438603pubmed:statusMEDLINElld:pubmed
pubmed-article:11438603pubmed:monthJullld:pubmed
pubmed-article:11438603pubmed:issn1529-2401lld:pubmed
pubmed-article:11438603pubmed:authorpubmed-author:LamFFlld:pubmed
pubmed-article:11438603pubmed:authorpubmed-author:LappiD ADAlld:pubmed
pubmed-article:11438603pubmed:authorpubmed-author:PorrecaFFlld:pubmed
pubmed-article:11438603pubmed:authorpubmed-author:VanderahT WTWlld:pubmed
pubmed-article:11438603pubmed:authorpubmed-author:OssipovM HMHlld:pubmed
pubmed-article:11438603pubmed:authorpubmed-author:MalanT PTPJrlld:pubmed
pubmed-article:11438603pubmed:authorpubmed-author:BurgessS ESElld:pubmed
pubmed-article:11438603pubmed:authorpubmed-author:GardellL RLRlld:pubmed
pubmed-article:11438603pubmed:issnTypeElectroniclld:pubmed
pubmed-article:11438603pubmed:day15lld:pubmed
pubmed-article:11438603pubmed:volume21lld:pubmed
pubmed-article:11438603pubmed:ownerNLMlld:pubmed
pubmed-article:11438603pubmed:authorsCompleteYlld:pubmed
pubmed-article:11438603pubmed:pagination5281-8lld:pubmed
pubmed-article:11438603pubmed:dateRevised2008-7-12lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:meshHeadingpubmed-meshheading:11438603...lld:pubmed
pubmed-article:11438603pubmed:year2001lld:pubmed
pubmed-article:11438603pubmed:articleTitleInhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.lld:pubmed
pubmed-article:11438603pubmed:affiliationDepartments of Pharmacology and Anesthesiology, University of Arizona, Tucson, Arizona 85724, USA. frankp@u.arizona.edulld:pubmed
pubmed-article:11438603pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11438603lld:pubmed
More...